ArticleAnnals of surgical oncology2025
The Impact of Travel Distance on Patient Outcomes after Breast Reconstruction.
Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundGeographical barriers can impact access to healthcare, but their influence on complications and long-term patient-reported outcomes (PROs) after breast reconstruction is unclear. This study evaluates the impact of travel distance on postoperative complications and PROs using the BREAST-Q. PATIENTS AND
methodsPatients who underwent postmastectomy breast reconstruction between 2017 and 2023 were categorized by travel distance into five groups (0-10, 11-25, 26-50, 51-100, 101+ miles). Complications assessed included wound infection, delayed wound healing, hematoma, mastectomy skin flap necrosis, and seroma. BREAST-Q domains-physical well-being of the chest (PWBC), psychosocial well-being (PSWB), satisfaction with breasts (SATSB), and sexual well-being (SWB)-were evaluated, when available, preoperatively and at 6 months and 1, 2, 3, 4, and 5 years. Linear mixed-effects (LME) modeling assessed travel distance as an independent predictor of PROs.
resultsAmong 5600 patients (4202 implant, 1398 autologous), wound infection rates differed significantly by travel distance in the implant cohort (p = 0.005), but other complications were consistent across groups. PROs were similar across travel distance groups for PWBC, PSWB, and SWB domains at all timepoints. SATSB scores varied significantly by travel distance at 1 years (p = 0.031), and 2 years (p = 0.008) postoperatively. LME modeling revealed minimal association between travel distance and PROs. Patients traveling 11-25 miles reported slightly higher SWB scores (p = 0.045) than those traveling 0-10 miles, but differences did not meet the minimally clinically important difference of 4 points.
conclusionsTravel distance did not meaningfully influence clinical outcomes or PROs, confirming patients can safely travel to specialized centers for breast reconstruction without compromising care or well-being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.